BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21570209)

  • 1. On the benefits and risks of proton therapy in pediatric craniopharyngioma.
    Beltran C; Roca M; Merchant TE
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e281-7. PubMed ID: 21570209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
    Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.
    Munck Af Rosenschöld P; Engelholm S; Ohlhues L; Law I; Vogelius I; Engelholm SA
    Acta Oncol; 2011 Aug; 50(6):777-83. PubMed ID: 21767174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes.
    Stützer K; Jakobi A; Bandurska-Luque A; Barczyk S; Arnsmeyer C; Löck S; Richter C
    J Appl Clin Med Phys; 2017 Nov; 18(6):104-113. PubMed ID: 28921843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT.
    Gutierrez A; Rompokos V; Li K; Gillies C; D'Souza D; Solda F; Fersht N; Chang YC; Royle G; Amos RA; Underwood T
    Acta Oncol; 2019 Dec; 58(12):1765-1774. PubMed ID: 31429359
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Baumert BG; Norton IA; Lomax AJ; Davis JB
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
    Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPY.
    Baues C; Marnitz S; Engert A; Baus W; Jablonska K; Fogliata A; Vásquez-Torres A; Scorsetti M; Cozzi L
    Radiat Oncol; 2018 Jul; 13(1):122. PubMed ID: 29970105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
    Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
    Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coplanar volumetric-modulated arc therapy (VMAT) for craniopharyngiomas reduces radiation doses to the bilateral hippocampus: a planning study comparing dynamic conformal arc therapy, coplanar VMAT, and non-coplanar VMAT.
    Uto M; Mizowaki T; Ogura K; Hiraoka M
    Radiat Oncol; 2016 Jun; 11():86. PubMed ID: 27338798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric advantage of intensity-modulated radiotherapy for whole ventricles in the treatment of localized intracranial germinoma.
    Sakanaka K; Mizowaki T; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e273-80. PubMed ID: 21640515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO
    Troost EGC; Wink KCJ; Roelofs E; Simone CB; Makocki S; Löck S; van Kollenburg P; Dechambre D; Minken AWH; van der Stoep J; Avery S; Jansen N; Solberg T; Bussink J; de Ruysscher D
    Br J Radiol; 2020 Mar; 93(1107):20190879. PubMed ID: 31804145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study.
    Yeung D; McKenzie C; Indelicato DJ
    Pediatr Blood Cancer; 2014 Jan; 61(1):89-94. PubMed ID: 24000229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
    Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
    Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study.
    Weber DC; Wang H; Cozzi L; Dipasquale G; Khan HG; Ratib O; Rouzaud M; Vees H; Zaidi H; Miralbell R
    Radiat Oncol; 2009 Sep; 4():34. PubMed ID: 19740429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma.
    Madani I; Lomax AJ; Albertini F; Trnková P; Weber DC
    Radiat Oncol; 2015 Mar; 10():72. PubMed ID: 25890217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
    Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
    Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region.
    Stuschke M; Kaiser A; Abu Jawad J; Pöttgen C; Levegrün S; Farr J
    Radiat Oncol; 2013 Jun; 8():145. PubMed ID: 23773560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.